Cingulate Inc. (CINGW) — 10-Q Filings

10-Q Filings (5)

• Cingulate's Cash Dwindles Amid Soaring Losses, Going Concern Warning Issued — Nov 13, 2025 Risk: high
  Cingulate Inc. reported a significant increase in net loss for the nine months ended September 30, 2025, reaching $16,177,001, up from $10,328,505 in the prior
• Cingulate Inc. Files Q1 2025 10-Q Report — May 8, 2025 Risk: medium
  Cingulate Inc. filed its quarterly report for the period ending March 31, 2025. The company, operating in the pharmaceutical preparations sector, is based in Ka
• Cingulate Inc. Files Q3 2024 10-Q Report — Nov 7, 2024 Risk: medium
  Cingulate Inc. filed its quarterly report for the period ending September 30, 2024. The company, operating in pharmaceutical preparations, reported its financia
• Cingulate Inc. Files 10-Q for Q2 2024 — Aug 13, 2024 Risk: medium
  Cingulate Inc. filed its 10-Q for the period ending June 30, 2024. The company, incorporated in Delaware and headquartered in Kansas City, KS, operates in the P
• Cingulate Inc. Files 10-Q for Period Ending March 31, 2024 — May 8, 2024 Risk: low
  Cingulate Inc. (CINGW) filed a Quarterly Report (10-Q) with the SEC on May 8, 2024. Cingulate Inc. filed a 10-Q report for the period ending March 31, 2024. The

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX